Health Care & Life Sciences » Biotechnology | Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. | Income Statement

Fiscal year is October-September. All values CAD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
17.40
7.70
91.90
-
-
Cost of Goods Sold (COGS) incl. D&A
98.80
-
212.40
130.00
120.90
Gross Income
81.40
-
120.50
130.00
120.90
SG&A Expense
948.50
7,259.60
2,957.30
2,175.00
6,107.10
EBIT
897.80
7,483.70
2,792.70
2,355.50
6,965.80
Unusual Expense
189.50
-
2,607.30
-
955.30
Non Operating Income/Expense
1.50
16.40
587.80
45.90
1.50
Interest Expense
13.70
142.70
5.10
10.80
6.50
Pretax Income
1,102.50
7,633.00
5,992.90
2,412.20
7,926.10
Income Tax
-
39.90
419.30
-
-
Equity in Affiliates
-
18.40
-
-
-
Consolidated Net Income
1,102.50
7,611.50
5,573.70
2,412.20
7,926.10
Net Income
1,102.50
7,569.40
4,472.50
2,339.40
7,634.10
Net Income After Extraordinaries
1,102.50
7,569.40
4,472.50
2,339.40
7,634.10
Net Income Available to Common
1,102.50
7,569.40
4,472.50
2,339.40
7,634.10
EPS (Basic)
0.04
0.16
0.06
0.02
0.05
Basic Shares Outstanding
26,066.00
48,803.80
68,819.40
94,996.10
148,669.50
EPS (Diluted)
0.04
0.16
0.06
0.02
0.05
Diluted Shares Outstanding
26,066.00
48,803.80
68,819.40
94,996.10
148,669.50
EBITDA
810.80
7,378.90
2,609.60
2,225.50
6,844.90
Other Operating Expense
132.00
127.00
285.00
50.50
737.80
Non-Operating Interest Income
-
9.70
-
-
-
Minority Interest Expense
-
42.10
1,101.10
72.80
292.10

About Abattis Bioceuticals

View Profile
Address
970 Burrard Street
Vancouver British Columbia V6Z 2R4
Canada
Employees -
Website http://www.abattis.com
Updated 07/08/2019
Abattis Bioceuticals Corp. is an agricultural technology and bio-technology company, which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. It operates through the following segments: Sciences, Products, and Technologies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.